Healthcare - Biotechnology - NASDAQ - US
$ 0.0002
0 %
$ 941
Market Cap
0.0
P/E
Price Target
Average
4999900.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
28.36%
Net Income
Estimate
--2.24%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
eFFECTOR Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for EFTR of $10 , with forecasts ranging from a low of $10 to a high of $10 .
EFTR Lowest Price Target
Wall Street Target
10 USD
4999900.00%
EFTR Average Price Target
Wall Street Target
10 USD
4999900.00%
EFTR Highest Price Target
Wall Street Target
10 USD
4999900.00%
REVENUE FORECAST
Revenue Forecast Chart EFTR
EBIT FORECAST
EBIT Forecast Chart EFTR
NET INCOME FORECAST
Net Income Chart EFTR